ENGES

News

First CBD (Cannabidiol) based drug for epilepsy patients in Colombia

First CBD (Cannabidiol) based drug for epilepsy patients in Colombia

For the first time in Colombia, patients with refractory epilepsy will be able to receive treatment with cannabis-based medicine. This new drug is the first and only INVIMA approved pharmaceutical grade Cannabidiol with scientific support.


Read more
Procaps, valued by the Ministry of Science as a highly innovative company

Procaps, valued by the Ministry of Science as a highly innovative company

The orientation towards innovation and the vision to contribute to solving health challenges has allowed Procaps to be a company permanently motivated to contribute to the construction of a healthier world.


Read more
WHO welcomes with satisfaction dexamethasone to treat COVID-19

WHO welcomes with satisfaction dexamethasone to treat COVID-19

Procaps, always committed to the well-being and health of all people, celebrates the findings of the mentioned research, while through the efforts of the Organization, it can contribute to the generation of products such as dexamethasone that allow recovery of patients severely affected by the coronavirus.


Read more
First semester tradeshows postponed

First semester tradeshows postponed

Know the postponed trade shows where we had a participation in first semester


Read more